Catalent Pharma Solutions, Inc. (CTLT)

Catalent Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Mar 31, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010	Jun 30, 2009
Revenue	1,813	1,800	1,695	1,532	1,480	1,562
Revenue Growth (YoY)	2.25%	6.22%	10.64%	3.47%	-5.20%	-14.09%
Cost of Revenue	1,231	1,232	1,136	1,030	1,040	1,167
Gross Profit	582	568.6	558.6	502.1	440.9	395
Selling, General & Admin	328.4	326.1	316.2	261.8	248.3	269.8
Research & Development	16.7	14.5	16.9	26.5	21.8	-
Operating Expenses	345.1	340.6	333.1	288.3	270.1	269.8
Operating Income	236.9	228	225.5	213.8	170.8	125.2
Interest Expense	-165.6	-203.5	-183.5	-165.4	-164.9	-192.6
Currency Exchange Gain (Loss)	-11.9	-5.7	17.1	-	25.1	-3.2
Other Non Operating Income (Expenses)	1.5	-7.3	-13	-26.1	-13.9	28.5
EBT Excluding Unusual Items	60.9	11.5	46.1	22.3	17.1	-42.1
Merger & Restructuring Charges	-17.6	-18.4	-34.5	-12.5	-17.7	-16.4
Asset Writedown	-1	-5.2	-1.8	-3.6	-214.8	-175.8
Other Unusual Items	3.1	-11.8	-	-11.6	-	-
Pretax Income	45.4	-23.9	18.6	-5.4	-215.4	-234.3
Income Tax Expense	41.5	24.1	16.5	23.7	21.9	17.2
Earnings From Continuing Operations	3.9	-48	2.1	-29.1	-237.3	-251.5
Earnings From Discontinued Operations	3.4	1.2	-41.3	-21	-49.7	-57.2
Net Income to Company	7.3	-46.8	-39.2	-50.1	-287	-308.7
Minority Interest in Earnings	0.9	0.1	-1.2	-3.9	-2.6	0.6
Net Income	8.2	-46.7	-40.4	-54	-289.6	-308.1
Net Income to Common	8.2	-46.7	-40.4	-54	-289.6	-308.1
Free Cash Flow	48.1	15.2	-16.3	12.4	163.3	-2
Gross Margin	32.10%	31.58%	32.96%	32.78%	29.78%	25.29%
Operating Margin	13.06%	12.67%	13.30%	13.96%	11.54%	8.02%
Profit Margin	0.45%	-2.59%	-2.38%	-3.52%	-19.56%	-19.73%
Free Cash Flow Margin	2.65%	0.84%	-0.96%	0.81%	11.03%	-0.13%
EBITDA	383.1	380.2	355.2	329.3	288.6	258.1
EBITDA Margin	21.13%	21.12%	20.96%	21.50%	19.50%	16.53%
D&A For EBITDA	146.2	152.2	129.7	115.5	117.8	132.9
EBIT	236.9	228	225.5	213.8	170.8	125.2
EBIT Margin	13.06%	12.67%	13.30%	13.96%	11.54%	8.02%
Effective Tax Rate	91.41%	-	88.71%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q